Literature DB >> 2161694

Incapacitating peripheral neuropathy as a manifestation of chronic graft-versus-host disease.

A Greenspan1, H J Deeg, M Cottler-Fox, M Sirdofski, T R Spitzer, J Kattah.   

Abstract

A 35-year-old caucasian man developed mild and transient signs of chronic graft-versus-host disease (GVHD) 5 months after bone marrow transplantation. At 16 months he presented with painful cramps in hands, feet, and truncal muscles. Electrophysiological studies revealed generalized sensory neuropathy. There was occasional fasciculation and high frequency motor units during involuntary muscle contractions, and agonist/antagonist cocontractions of peripheral muscle groups (non-continuous). A sural nerve biopsy showed Schwann cells and macrophages with myelin debris, and Schwann cell stacks with collagen pockets. The patient's symptoms responded to treatment with glucocorticoids and azathioprine. We propose that this patient's incapacitating polyneuropathy was a major manifestation of chronic GVHD, suggesting that the peripheral and possibly central nervous systems can be targets of chronic GVHD.

Entities:  

Mesh:

Year:  1990        PMID: 2161694

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  3 in total

1.  Steroid-responsive chronic inflammatory demyelinating polyradiculoneuropathy post-hematopoietic stem cell transplantation: a case report and literature review.

Authors:  Yunxia Zhao; Xiuying Chen; Wen Zhang; Xiaosheng Fang; Xiaohui Liu; Wei Dong
Journal:  Neurol Sci       Date:  2021-07-31       Impact factor: 3.307

2.  Muscle cramps and neuropathies in patients with allogeneic hematopoietic stem cell transplantation and graft-versus-host disease.

Authors:  Peter D Kraus; Daniel Wolff; Oliver Grauer; Klemens Angstwurm; Sven Jarius; Klaus P Wandinger; Ernst Holler; Wilhelm Schulte-Mattler; Ingo Kleiter
Journal:  PLoS One       Date:  2012-09-17       Impact factor: 3.240

Review 3.  Stem Cell Therapy in Neuroimmunological Diseases and Its Potential Neuroimmunological Complications.

Authors:  Franz Felix Konen; Philipp Schwenkenbecher; Konstantin Fritz Jendretzky; Stefan Gingele; Lea Grote-Levi; Nora Möhn; Kurt-Wolfram Sühs; Britta Eiz-Vesper; Britta Maecker-Kolhoff; Corinna Trebst; Thomas Skripuletz; Martin W Hümmert
Journal:  Cells       Date:  2022-07-11       Impact factor: 7.666

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.